Insights On Trial Design
-
Everything You Need To Know About Mobile Visits And Community Sites
10/11/2024
Discover how decentralized clinical trials (DCTs) and mobile visits contribute to more diverse, efficient, and patient-centric research, ultimately enhancing trial outcomes and data quality.
-
Your Biggest Unblinding Risk? Inexperienced Staff
4/28/2026
Protect study integrity by closing the gaps in IRT workflows. Learn why rushed communication and training lapses lead to accidental unblinding and how to safeguard your clinical data.
-
Are Transportation Failures Really Logistics Problems?
6/15/2026
Missed clinical visits stem from fragmented financial workflows — not transport. Integrating payments, approvals, and travel cuts delays, boosts participation, and keeps studies on track.
-
Why Operational Design Determines Recruitment And Retention
4/22/2026
Patient recruitment challenges often receive the most attention in clinical trials, yet many enrollment and retention issues stem from operational friction embedded in study design.
-
The Implications Of Semaglutide's Connect To Increased Risk Of NAION
2/18/2025
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
-
RTSM And IRT Solutions For Clinical Trials
12/10/2025
Global leader in RTSM/IRT, helping sponsors and CROs speed study start-up, optimize supply, and manage complex trials with confidence.
-
From Data Delays To Decision Speed
7/31/2026
The biggest risk in modern trials isn’t missing data. It’s delayed insight. Discover how real-time intelligence helps teams act faster, reduce risk, and improve trial execution.
-
FDA Guidance On Payment And Reimbursement To Research Subjects
12/5/2025
Learn how ethical, fair, and timely payment and reimbursement strategies can support participants, enhance trial accessibility, and uphold regulatory and IRB standards.
-
Challenges, Opportunities For Recruitment In The Digital Age
10/20/2025
Health literacy gaps and online misinformation hinder clinical trial recruitment. Meeting patients where they are — digitally and educationally — can improve engagement and enrollment success.
-
Breaking Silos In Drug Development: The Power Of An Integrated Model
5/11/2026
Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.